Medication and prescription reviews

Medication and prescription reviews

1. Two nonprescription products have different brand names. What should a medication review still compare?
   • Their active ingredients, because different products may contain the same ingredient.
   • Only the package colors, because different brands cannot overlap.
   • Only which product was purchased more recently.
   • Not sure yet

   Correct answer: Their active ingredients, because different products may contain the same ingredient.

   FDA warns that different over-the-counter products may contain the same active ingredient. Comparing brand names alone can therefore miss duplication and the possibility of taking too much of an ingredient. A review should use the actual labels and product list, rather than assuming that separately marketed medicines are automatically safe to combine.

   Source: FDA (opens a new tab)
2. Why might a pharmacist ask about alcohol or other beverages during a medication discussion?
   • Beverages cannot change any medicine’s effects.
   • Only the time a bottle was purchased can affect interaction risk.
   • Interactions can involve food or beverages, not only combinations of prescription medicines.
   • Not sure yet

   Correct answer: Interactions can involve food or beverages, not only combinations of prescription medicines.

   FDA describes drug-food and drug-beverage interactions and gives alcohol with some medicines as an example that may increase tiredness or slow reactions. A useful review can ask what accompanies a medicine as well as what other medicines are taken. This question does not define a safe amount or approve any particular combination.

   Source: FDA (opens a new tab)
3. Why can an existing health condition matter when considering a nonprescription cold product?
   • Nonprescription medicines are exempt from all health-condition warnings.
   • Drug-condition interactions can make some products unsuitable or potentially harmful.
   • The same product is suitable for everyone who has the same cold symptom.
   • Not sure yet

   Correct answer: Drug-condition interactions can make some products unsuitable or potentially harmful.

   FDA describes drug-condition interactions, including unwanted reactions to some nasal decongestants in people with high blood pressure. The example explains why a review includes medical history and the actual label. It is not a recommendation to choose a different cold product or alter existing blood-pressure treatment without individualized advice.

   Source: FDA (opens a new tab)
4. Someone has used the same nonprescription medicine for years. Why read its label again?
   • Warnings and other label information can change as new information becomes available.
   • Past use guarantees that the current product has no warnings.
   • Only the advertising slogan matters once a product is familiar.
   • Not sure yet

   Correct answer: Warnings and other label information can change as new information becomes available.

   FDA recommends reading the label every time a medicine is used because label information may change. The active ingredients, directions, and warnings are more useful than familiarity with a brand. A medication review can clarify current information without assuming that a previously tolerated product remains appropriate in every new situation.

   Source: FDA (opens a new tab)
5. Which discussion goes beyond simply asking whether a refill is wanted?
   • Assuming the medicine name explains its purpose and directions completely.
   • Treating every refill request as proof that no review is needed.
   • Clarifying why the medicine was prescribed, how it is taken, and the intended duration.
   • Not sure yet

   Correct answer: Clarifying why the medicine was prescribed, how it is taken, and the intended duration.

   NIA recommends understanding a medicine’s name and purpose and asking how often and for how long it should be taken. A useful review checks that those details remain understood rather than treating the prescription as a name alone. This lab does not authorize a refill or establish which prescribing services a practice offers.

   Source: NIH/NIA (opens a new tab)
6. What is a reasonable question when a medicine is too expensive?
   • Can I assume all cheaper products are interchangeable without a review?
   • Could an appropriate generic or another less expensive option be discussed?
   • Does cost mean that the treatment concern should never be mentioned again?
   • Not sure yet

   Correct answer: Could an appropriate generic or another less expensive option be discussed?

   NIA encourages asking about medication cost and whether a generic or another less expensive choice might be appropriate. That opens a practical conversation; it does not guarantee an alternative or insurance coverage. The actual choice still depends on the medicine, the clinical situation, and the treating professional’s review.

   Source: NIH/NIA (opens a new tab)
7. A fictional patient says a medicine seems unhelpful or is causing problems. Which review principle is supported?
   • Tell the treating clinician about the concern and discuss any proposed change before stopping.
   • Keep concerns out of the review because they cannot affect the treatment plan.
   • Use a learning-quiz result to decide a new dose immediately.
   • Not sure yet

   Correct answer: Tell the treating clinician about the concern and discuss any proposed change before stopping.

   NIA recommends telling the doctor when a medicine does not seem to work or causes problems and checking before stopping it. Those concerns can change what needs review. This answer does not instruct someone to ignore a reaction, continue through an emergency, or change treatment here; it explains why a clear clinical contact plan matters.

   Source: NIH/NIA (opens a new tab)
8. A medication label is unclear about a possible interaction. What is the most useful next discussion?
   • Assume all interaction warnings apply identically to every medicine.
   • Treat a general educational example as a complete check of the person’s medicine list.
   • Ask a doctor or pharmacist using the actual medicine labels and relevant treatment information.
   • Not sure yet

   Correct answer: Ask a doctor or pharmacist using the actual medicine labels and relevant treatment information.

   FDA advises asking a doctor or pharmacist for more information when questions remain after reading a label. Its interaction examples are not a complete list of warnings. A review should therefore address the actual products and health context, rather than treating this learning lab or one example as a personalized interaction checker.

   Source: FDA (opens a new tab)